GO
Loading...

Lightning Round: Qualcomm, GenCorp & more

Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

Qualcomm (QCOM): It's a buy, said Cramer. Wall Street is addicted to this stock. I'd buy half a position now and the other half on negative news.

PTC Therapeutics (PTCT): I think biotechs deserve a long hard look after Merck acquired hepatitis C maker Idenix for $24.50 per share, more than three times Idenix's Friday closing price of $7.23, Cramer said.

Getty Images

GenCorp (GY): I'm a buyer, said Cramer. It's a good situation.

Freeport-McMoRan (FCX): I'm not a fan, said Cramer. In the space I'd rather own Alcoa.



Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
PTCT
---
GY
---
FCX
---
YHOO
---
TRN
---
POT
---
CXO
---
DSX
---
QCOM
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.